| PUBLICATIONS (Ranked by impact factor of the journal) | LABORATORY RESEARCH XMRV Induces Cell Migration, Cytokine Expression and Tumor Angiogenesis: Are 22Rv1 Cells a Suitable Prostate Cancer Model? Scientists demonstrated that 22Rv1 cells with reduced retroviral transcription show reduced tumor angiogenesis and increased necrosis of the primary tumor derived from xenografted cells in scid mice when compared to the parental cell line. [PLoS One] Full Article In Vivo Biomarker Expression Patterns Are Preserved in 3D Cultures of Prostate Cancer Investigators report that prostate cancer cell-lines DU145, PC3, LNCaP and RWPE-1 grown in 3D matrices in contrast to conventional 2D monolayers, display distinct differences in cell morphology, proliferation and expression of important biomarker proteins associated with cancer progression. [Exp Cell Res] Abstract Human Papillomavirus and Epstein Barr Virus in Prostate Cancer: Koilocytes Indicate Potential Oncogenic Influences of Human Papillomavirus in Prostate Cancer Scientists indentified both human papillomaviruses type 18 and Epstein Barr virus gene sequences in a high and approximately equal proportion of normal, benign, and prostate cancer specimens. [Prostate] Abstract | Press Release Evaluation of a Technetium-99m Labeled Bombesin Homodimer for GRPR Imaging in Prostate Cancer Researchers developed a new bombesin homodimer based on an ε-aminocaproic acid-bombesin(7–14) fragment, which has been studied for targeting the gastrin-releasing peptide receptor (GRPR) in prostate cancer. [Amino Acids] Abstract Demethoxycurcumin Modulates Prostate Cancer Cells Proliferation via AMPK-Induced Down-Regulation of Heat Shock Protein 70 and Epidermal Growth Factor Receptor Investigators examined the effects of three curcuminoid analogs on prostate cancer cells. Results revealed that demethoxycurcumin demonstrated the most efficient cytotoxic effects on prostate cancer PC3 cells. [J Agric Food Chem] Abstract Tumor Suppressive MicroRNAs (miR-222 and miR-31) Regulate Molecular Pathways Based on MicroRNA Expression Signature in Prostate Cancer Researchers focused on four downregulated microRNAs (miR-187, miR-205, miR-222 and miR-31) to investigate their functional significance in prostate cancer cells. [J Hum Genet] Abstract Identification of Ryanodine Receptor Isoforms in Prostate DU-145, LNCaP, and PWR-1E Cells Scientists identified the ryanodine receptor isoforms expressed in widely used prostate cancer cell lines, DU-145 and LNCaP, and the non-tumorigenic prostate cell line, PWR-1E. [Biochem Biophys Res Commun] Abstract Expression of Melanocortin Receptors in Human Prostate Cancer Cell Lines: MC2R Activation by Adrenocorticotropic Hormone Increases Prostate Cancer Cell Proliferation Investigators showed that melanocortin receptors (MCR) (1-5) mRNAs are expressed in androgen-dependent LNCaP and androgen-independent PC3 and DU-145 human prostate cancer cell lines. [Int J Oncol] Abstract Glycosylation Potential of Human Prostate Cancer Cell Lines Researchers investigated enzymatic activities and gene expression levels of key glycosyl- and sulfotransferases responsible for the assembly of O- and N-glycans in several prostatic cells. [Glycoconj J] Abstract CLINICAL RESEARCH Long Term Results of a Prospective Dose Escalation Phase-II Trial: Interstitial Pulsed-Dose-Rate Brachytherapy as Boost for Intermediate- and High-Risk Prostate Cancer Scientists report on a seven year single institution experience with pulsed dose rate brachytherapy dose escalation study in patients with intermediate and high risk prostate cancer. [Radiother Oncol] Abstract Phase II Study of First-Line Sagopilone plus Prednisone in Patients with Castration-Resistant Prostate Cancer: A Phase II Study of the Department of Defense Prostate Cancer Clinical Trials Consortium Researchers investigated the activity and safety of sagopilone in patients with metastatic castration-resistant prostate cancer. [Br J Cancer] Abstract |
| JOB OPPORTUNITIES | Quality Control Operations Coordinator (STEMCELL Technologies, Inc.) Research Associate – Chemistry (STEMCELL Technologies, Inc.) Research Associate – Particle Chemistry (STEMCELL Technologies, Inc.) Research Technologist – Research and Development (STEMCELL Technologies, Inc.) Research Technologist – Contract Assay Services (STEMCELL Technologies, Inc.) Research Technologist – Media Development (STEMCELL Technologies, Inc.) Scientist – Epithelial Cell Research (STEMCELL Technologies, Inc.) Scientist – Induced Pluripotent Stem Cells (STEMCELL Technologies, Inc.) Scientist – Mesenchymal Cell Research (STEMCELL Technologies, Inc.) Scientist – hPSC Bioengineering (STEMCELL Technologies, Inc.) Postdoctoral Position – Prostate Cancer (BC Cancer Agency) Postdoctoral Position – Endocrinology of Prostate Cancer (Baylor College of Medicine) Postdoctoral Position – Prostate Cancer Research (University of Texas Southwestern Medical Center) Postdoctoral Position – Systems Biology in Prostate Cancer (Karolinska Institutet) Recruit Top Talent: Reach more than 55,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost. |
|
|
|